ASCO GI 2022 Conference Coverage
Playback speed
10 seconds
ASCO GI 2022 Updates on the Dose-Escalation & Dose-Expansion Study of T-DXd Monotherapy and Combinations in Advanced /Metastatic HER2+ GC/GEJA: DESTINY-Gastric03
By
ASCO GI 2022 Conference Coverage
FEATURING
Yelena Y. Janjigian
By
ASCO GI 2022 Conference Coverage
FEATURING
Yelena Y. Janjigian
230 views
February 1, 2022
Login to view comments.
Click here to Login
Videos